Literature DB >> 7927308

Spermatocytic seminoma.

J N Eble1.   

Abstract

Spermatocytic seminoma is a rare testicular neoplasm that occurs only in adults (range, 25 to 87 years; mean, 54). It has no ovarian homologue and is found only in descended testes. It is not associated with other types of germ cell neoplasia. Orchiectomy is curative in virtually all cases; of more than 200 known cases, only one has metastasized. In a dozen cases sarcomas have arisen in the testes in association with spermatocytic seminoma; most of these patients have died of metastatic sarcoma after short intervals. The gross appearance is characteristically edematous or gelatinous and more than half the tumors have been more than 5 cm in diameter. Microscopically, they are composed of sheets of small, medium, and large cells with spherical nuclei. The chromatin is dense in the small cells and filamentous in the medium and large ones. The cytoplasm is eosinophilic to amphophilic and lacks glycogen. It is not associated with intratubular germ cell neoplasia of the undifferentiated type. Analyses of DNA content have failed to show haploid populations and the lectin binding does not show maturation toward spermatocytes. Differing from seminoma in essentially all characteristics, it is not a variant of seminoma.

Entities:  

Mesh:

Year:  1994        PMID: 7927308     DOI: 10.1016/0046-8177(94)90062-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  20 in total

Review 1.  [Spermatocytic seminoma. A tumor with many faces].

Authors:  G Mikuz
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

2.  Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors.

Authors:  H Herbst; M Sauter; N Mueller-Lantzsch
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Detection of human endogenous retrovirus type K-specific transcripts in testicular parenchyma and testicular germ cell tumors of adolescents and adults: clinical and biological implications.

Authors:  H Roelofs; R J van Gurp; J W Oosterhuis; L H Looijenga
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

Review 4.  Poor efficacy of BEP polychemotherapy in metastatic spermatocytic seminoma.

Authors:  Thomas Horn; Stephan Schulz; Tobias Maurer; Jürgen E Gschwend; Hubert R Kübler
Journal:  Med Oncol       Date:  2010-11-18       Impact factor: 3.064

5.  Ki-A10, a germ cell nuclear antigen retained in a subset of germ cell-derived tumors.

Authors:  P Rudolph; U Kellner; D Schmidt; V Kirchner; A Talerman; D Harms; R Parwaresch
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

6.  Intermitochondrial cement (nuage) in a spermatocytic seminoma: comparison with classical seminoma and normal testis.

Authors:  Manrico Morroni; Angela Maria Cangiotti; Daniela Marzioni; Antonella D'Angelo; Rosaria Gesuita; Michele De Nictolis
Journal:  Virchows Arch       Date:  2008-04-19       Impact factor: 4.064

7.  Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance.

Authors:  E Rajpert-De Meyts; M Kvist; N E Skakkebaek
Journal:  Virchows Arch       Date:  1996-06       Impact factor: 4.064

Review 8.  New insights into the pathology and molecular biology of human germ cell tumors.

Authors:  Friedemann Honecker; J Wolter Oosterhuis; Frank Mayer; Jörg Thomas Hartmann; Carsten Bokemeyer; Leendert H J Looijenga
Journal:  World J Urol       Date:  2004-03-20       Impact factor: 4.226

9.  Spermatocytic seminoma: a 21 years' retrospective study in a tertiary care hospital in Pakistan.

Authors:  Saroona Haroon; Muhammad Usman Tariq; Saira Fatima; Naila Kayani
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

10.  Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.

Authors:  Anne Goriely; Ruth M S Hansen; Indira B Taylor; Inge A Olesen; Grete Krag Jacobsen; Simon J McGowan; Susanne P Pfeifer; Gilean A T McVean; Ewa Rajpert-De Meyts; Andrew O M Wilkie
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.